What's breaking now, across thousands of outlets.
Beeline Medicines fleshed out an impressive mid-stage win in systemic lupus on Wednesday, setting the stage for Phase 3 trials with a former drug from Bristol Myers Squibb. At each of three doses tested, Beeline’s ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Now that the UK government has increased its spending on medicines, it’s calling for life sciences companies to do their part and invest on home soil. “We are determined to ensure that the UK is ...
New research led by QIMR Berghofer has uncovered a decades-long increase in the rates of a common form of skin cancer across Australia and Europe, highlighting a growing but underrecognized public…
From the Handelsblatt archive: Investors and pharmaceutical companies are investing billions in products for women in menopause. Nevertheless, there is a lack of effective therapies.
The study of more than 1,800 older Australians found that people who had experienced lifetime trauma were more likely to have mild cognitive impairment (MCI) or dementia and performed worse on working memory and executive function tests.
